Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 0.63 |
| ▸ | CA1 | P00915 | 7/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.63 |
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
| ▸ | ATIC | P31939 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.49 |
| ▸ | NSD2 | O96028 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.47 |
| ▸ | CASP6 | P55212 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30440356 | 1.00 | CA2 (0.63) | CA2CA1CA9PLAUATIC | |
| SCHEMBL29516390 | 0.85 | PLAU (0.56) | CA2CA1CA9PLAUATIC | |
| SCHEMBL342865 | 0.85 | PLAU (0.56) | CA2CA1CA9PLAUATIC | |
| SCHEMBL3849624 | 0.84 | PLAU (0.55) | CA2CA1CA9PLAUATIC | |
| SCHEMBL8494394 | 0.84 | PLAU (0.50) | CA2CA1CA9PLAUATIC | |
| SCHEMBL3849618 | 0.82 | HTR6 (0.50) | CA2CA1CA9PLAUATIC | |
| SCHEMBL6562190 | 0.82 | PLAU (0.49) | CA2CA1CA9PLAUATIC | |
| SCHEMBL1805507 | 0.81 | CA2 (0.63) | CA2CA1CA9ATICHTR6 | |
| SCHEMBL1807861 | 0.80 | CA2 (0.61) | CA2CA1CA9ATICHTR6 | |
| SCHEMBL1805508 | 0.80 | CA2 (0.61) | CA2CA1CA9ATICHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1779117-B1 | METHODS FOR MEASURING ADAMTS13 ACTIVITY ON THE SURFACE OF PLATELETS | AMERICAN DIAGNOSTICA INC (US) | 2010-05-19 | — | — | EP | claimed |
| EP-1779117-A4 | METHODS FOR MEASURING ADAMTS13 ACTIVITY AND PROTEIN ON PLATELETS AND IN PLASMA | AMERICAN DIAGNOSTICA INC (US) | 2008-02-20 | — | — | EP | claimed |
| US-7270976-B2 | Methods for measuring ADAMTS13 activity and protein on platelets and in plasma | AMERICAN DIAGNOSTICA, INC. (US) | 2007-09-18 | — | — | US | claimed |
| EP-1779117-A1 | METHODS FOR MEASURING ADAMTS13 ACTIVITY AND PROTEIN ON PLATELETS AND IN PLASMA | American Diagnostica Inc. (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006019379-A1 | METHODS FOR MEASURING ADAMTS13 ACTIVITY AND PROTEIN ON PLATELETS AND IN PLASMA | AMERICAN DIAGNOSTICA INC. (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060014233-A1 | Methods for measuring ADAMTS13 activity and protein on platelets and in plasma | BIOMEDICA DIAGNOSTICS INC. (CA) | 2006-01-19 | — | — | US | claimed |
| EP-1007078-A4 | PEPTIDOMIMETICS CONTAINING 6-PEPTIDYLAMINO-1-NAPHTHALENESULFONAMIDE MOIETIES | BUTENAS SAULIUS (US) | 2002-11-13 | — | — | EP | claimed |
| US-6194143-B1 | MEASUREMENT ACTIVITY BY MONITORING SUBSTRATE CLEAVAGE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-02-27 | — | — | US | claimed |
| EP-1007078-A1 | PEPTIDOMIMETICS CONTAINING 6-PEPTIDYLAMINO-1-NAPHTHALENESULFONAMIDE MOIETIES | Butenas, Saulius (US) | 2000-06-14 | — | — | EP | claimed |
| EP-0948640-A2 | IMPROVED SUBSTRATES FOR HUMAN CYTOMEGALOVIRUS PROTEASE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1999-10-13 | — | — | EP | claimed |
| WO-1998022125-A9 | PEPTIDOMIMETICS CONTAINING 6-PEPTIDYLAMINO-1-NAPHTHALENESULFONAMIDE MOIETIES | — | 1998-10-08 | — | — | WO | claimed |
| WO-1998029562-A2 | IMPROVED SUBSTRATES FOR HUMAN CYTOMEGALOVIRUS PROTEASE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1998-07-09 | — | — | WO | claimed |
| WO-1998022125-A1 | PEPTIDOMIMETICS CONTAINING 6-PEPTIDYLAMINO-1-NAPHTHALENESULFONAMIDE MOIETIES | BUTENAS SAULIUS (US) | 1998-05-28 | — | — | WO | claimed |
| US-20250389737-A1 | FACTOR Xa REAGENT | INSTR LABORATORY CO (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4667582-A1 | FACTOR XA REAGENT | Instrumentation Laboratory Company (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250361322-A1 | ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND RELATED METHODS | ICONIC THERAPEUTICS LLC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-0065595-A2 | Water-soluble triazine compounds, their preparation and their use | BAYER AG (DE) | 1982-12-01 | — | — | EP | disclosed |
| EP-0002041-A1 | Processes for synthesizing bisazomethine-bisazo pigments | CIBA-GEIGY AG (CH) | 1979-05-30 | — | — | EP | disclosed |
| US-4086223-A | Asymmetrical 1:2-chromium complex azo dyestuffs | CIBA-GEIGY AG (CH) | 1978-04-25 | — | — | US | disclosed |
| US-4083844-A | Phenylazo orthocyano phenylazo or orthocyano phenylazo phenylazo containing dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389737-A1 | FACTOR Xa REAGENT | F9, F11, TFPI | CA2 2625/4885CA1 1458/4885CA9 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.